Literature DB >> 4939243

The immunogenesis of the multiple sclerosis plaque.

C E Lumsden.   

Abstract

Mesh:

Substances:

Year:  1971        PMID: 4939243     DOI: 10.1016/0006-8993(71)90052-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


× No keyword cloud information.
  50 in total

1.  Anti-macrophage CR3 antibody blocks myelin phagocytosis by macrophages in vitro.

Authors:  W Brück; R L Friede
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

Review 2.  Complementing the inflammasome.

Authors:  Martha Triantafilou; Timothy R Hughes; Bryan Paul Morgan; Kathy Triantafilou
Journal:  Immunology       Date:  2016-02       Impact factor: 7.397

Review 3.  Role of microglia in multiple sclerosis.

Authors:  Xinqing Deng; Subramaniam Sriram
Journal:  Curr Neurol Neurosci Rep       Date:  2005-05       Impact factor: 5.081

Review 4.  Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis.

Authors:  Madhan Kolappan; Andrew P D Henderson; Thomas M Jenkins; Claudia A M Wheeler-Kingshott; Gordon T Plant; Alan J Thompson; David H Miller
Journal:  J Neurol       Date:  2009-03-18       Impact factor: 4.849

5.  Enzymic hydrolysis of myelin basic protein and other proteins in central nervous system and lymphoid tissues from normal and demyelinating rats.

Authors:  G F Buletza; M E Smith
Journal:  Biochem J       Date:  1976-06-15       Impact factor: 3.857

6.  Altered regulation of mitogen responsiveness by suppressor cells in multiple sclerosis.

Authors:  R L Gonzalez; P C Dau; L E Spitler
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

7.  Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies.

Authors:  P Vanguri; C L Koski; B Silverman; M L Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

8.  The significance of perivascular infiltrations in multiple sclerosis.

Authors:  A Guseo; K Jellinger
Journal:  J Neurol       Date:  1975-12-02       Impact factor: 4.849

9.  Targeted inhibition of complement using complement receptor 2-conjugated inhibitors attenuates EAE.

Authors:  Xianzhen Hu; Stephen Tomlinson; Scott R Barnum
Journal:  Neurosci Lett       Date:  2012-10-16       Impact factor: 3.046

Review 10.  Complement in multiple sclerosis: its role in disease and potential as a biomarker.

Authors:  G Ingram; S Hakobyan; N P Robertson; B P Morgan
Journal:  Clin Exp Immunol       Date:  2008-11-24       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.